A medicine called Kemocarb (Carboplatin Injection) contains carboplatin, a platinum-based chemotherapeutic agent used to treat cancer. The injection is recommended for a number of cancers, including lung cancer, testicular cancer, and ovarian cancer. Cancer cells' DNA is damaged by carboplatin, which prevents the growth and division of such cells. An experienced healthcare practitioner administers the shot intravenously. Low blood cell counts, hair loss, nausea, and vomiting are examples of typical adverse effects. Kemocarb 450 mg has shown to be beneficial in treating a number of malignancies, providing patients with these diseases with potential advantages and better prognoses. Individual responses to the medicine, however, may differ, necessitating constant medical supervision throughout the course of treatment.